« Back to Record
Citation APA

Awada, A., Giacchetti, S., Gérard, B., Eftekhary, P., Lucas, C., de Valeriola, D., Poullain, M. G., Soudon, J., Dosquet, C., Brillanceau, M.-H., Giroux, B., Marty, M., Bleiberg, H., Calvo, F., & Piccart-Gebhart, M. (2002). Clinical phase I and pharmacokinetic study of S 16020, a new olivacine derivative: report on three infusion schedules. Annals of oncology, 13(12), 1925-1934. doi:10.1093/annonc/mdf321


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/53691

Awada, A., Giacchetti, S., Gérard, B., Eftekhary, P., Lucas, C., de Valeriola, D., Poullain, M. G., Soudon, J., Dosquet, C., Brillanceau, M.-H., Giroux, B., Marty, M., Bleiberg, H., Calvo, F., & Piccart-Gebhart, M. (2002). Clinical phase I and pharmacokinetic study of S 16020, a new olivacine derivative: report on three infusion schedules. Annals of oncology, 13(12), 1925-1934. doi:10.1093/annonc/mdf321